Castration Resistant Prostate Cancer (CRPC): State of the Art, Perspectives and New Challenges

E-ISSN： 1875-5992|13|6|872-886

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.13, Iss.6, 2013-07, pp. : 872-886

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)

By Meulenbeld Hielke Bono Johann Tagawa Scott Whang Young Li Xiaoyun Heath Karl Zandvliet Anthe Ebbinghaus Scot Hudes Gary Wit Ronald

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 909-916

Springer Publishing Company

Access to resources Recommend Favorite

New Therapeutic Strategies for Castration-Resistant Prostate Cancer

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 373-383

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular mechanisms of castration-resistant prostate cancer progression

By Dutt Smitha S Gao Allen C

Future Oncology, Vol. 5, Iss. 9, 2009-11 ,pp. : 1403-1413

Future Medicine

Access to resources Recommend Favorite

Developing imaging strategies for castration resistant prostate cancer

By Fox Josef J. Morris Michael J. Larson Steven M. Schööder Heiko Scher Howard I.

Acta Oncologica, Vol. 50, Iss. 1, 2011-06 ,pp. : 39-48

Informa Healthcare

Access to resources Recommend Favorite

The role of enzalutamide in the treatment of castration-resistant prostate cancer

By Rawlinson Alex Mohammed Aza Miller Marek Kunkler Roger

Future Oncology, Vol. 8, Iss. 9, 2012-09 ,pp. : 1073-1081

Future Medicine

Access to resources Recommend Favorite